Cargando…
Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTileⓇ Brachytherapy
Glioblastoma recurrence between initial resection and standard-of-care adjuvant chemoradiotherapy (CRT) is a negative prognostic factor in an already highly aggressive disease. Re-resection with GammaTileⓇ(GT Medical Technologies Inc., Tempe, AZ) placement affords expedited adjuvant radiation to mit...
Autores principales: | Easwaran, Teresa P, Sterling, David, Ferreira, Clara, Sloan, Lindsey, Wilke, Christopher, Neil, Elizabeth, Shah, Rena, Chen, Clark C, Dusenbery, Kathryn E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666087/ https://www.ncbi.nlm.nih.gov/pubmed/34912636 http://dx.doi.org/10.7759/cureus.19496 |
Ejemplares similares
-
GammaTile® brachytherapy in the treatment of recurrent glioblastomas
por: Gessler, Dominic J, et al.
Publicado: (2021) -
GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis
por: Dharnipragada, Rajiv, et al.
Publicado: (2023) -
GammaTile for Gliomas: A Single-Center Case Series
por: Budnick, Hailey C, et al.
Publicado: (2021) -
Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas
por: Ng, Sook Kien, et al.
Publicado: (2023) -
Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method
por: Arsenault, Theodore, et al.
Publicado: (2021)